Drug Microarray Patch
Technical Development
WCC has received government support to develop MNP that contains insulin for diabetic patients. It took WCC one year to develop the an effective MNP with insulin, currently WCC is seeking cooperation on this product. In the meantime, WCC has established solid foundation to include different drugs such as pain killers, hormones and others into MNP. Several pharmaceutical companies are currently discussing with WCC on the possibility to include various drugs into MNP.
Applicaiton
Diabetes, HGH, Antiemetic, Pain-relief
Advantages
1. Dosage can be precisely controlled
2. Exclusive controlled release mechanism
3. Feasible to submit 505(b)2 regulatory pathway
Cooperation
ODM/RD or others